53 studies found for:
" September 15, 2009":" October 15, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Unknown † |
Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
|
||||
| 2 | Completed |
Profile of HIV Seropositive Patients
|
||||
| 3 | Completed |
The Shang Ring: A Novel Male Circumcision Device for HIV Prevention
|
||||
| 4 | Completed |
Genotype Based Personalized Prescription of Nevirapine
|
||||
| 5 | Active, not recruiting |
Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
|
||||
| 6 | Recruiting |
TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents
|
||||
| 7 | Completed |
Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
|
||||
| 8 | Completed |
Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers
|
||||
| 9 | Unknown † |
Pilot Assessment of Lopinavir/Ritonavir and Maraviroc
|
||||
| 10 | Active, not recruiting |
Europe-Africa Research Network for Evaluation of Second-line Therapy
|
||||
| 11 | Completed |
Study of Vitamin D Supplementation to Male HIV Sero-positive Patients
|
||||
| 12 | Completed |
QoL and Adherence to One-pill Once-a-day HAART
|
||||
| 13 | Completed |
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1
|
||||
| 14 | Unknown † |
The St. Marys and The Mater Switch Study
|
||||
| 15 | Completed |
The Women's HIV SeroIncidence Study (ISIS)
|
||||
| 16 | Recruiting |
Using Heavy Water to Study Cell Dynamics in Parkinson's Disease
|
||||
| 17 | Completed |
HIV Testing in the Emergency Department at Baystate Medical Center: A Pilot Program
|
||||
| 18 | Recruiting |
Redirected High Affinity Gag‐Specific Autologous T Cells for HIV Gene Therapy
|
||||
| 19 | Active, not recruiting |
Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels
|
||||
| 20 | Completed |
Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults
|
† Indicates status has not been verified in more than two years
